Flaum Eye Institute News Blog
New NIH-Funded Project Targets Early Drivers of Vision Loss in Macular Degeneration
Age-related macular degeneration (AMD) is a disease that has few effective treatments for patients diagnosed with it. However, thanks to a National Institutes of Health (NIH) grant, promising new research has developed at the Flaum Eye Institute that could slow or prevent the eye damage that leads to blindness in patients with AMD.Avery's Eyes: A Child's Journey From Long Island To Rochester
Avery was born with a rare eye disease that threatened her vision and quality of life. Her journey came to Rochester and Dr. Alex Levin, who discovered her disease was something else entirely. Levin, along with Dr. Matthew Haynie, took Avery into their care, performing multiple surgeries. Her family was so grateful for the care she received, they wanted to give back to show their appreciation.Seeing the Whole Picture: A New Model of Behavioral Health in Ophthalmic Care
First-of-its-kind eye care model delivers real-time social and emotional well-being into ophthalmology clinics.Flaum Eye Institute scientists part of multi-institutional effort to make in-home vision rehabilitation a “virtual” reality
With the help of NIH, Flaum researchers are working on a specialized headset to diagnose visual defects, with the goal of making lab-based treatments more accessible for patients.
